RxDoctor Payments DataLook up a doctor →

Jeffrey Overcash, MD

Emergency Medicine · Chula Vista, CANPI 1104814680

Payments from drug & device makers

$31,831,104in general payments, 2019–2025

Across 7,257 payments — averaging $4386.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$17M
  • Sanofi Pasteur Inc.$2.8M
  • Eli Lilly$1.5M
  • Regeneron$1.2M
  • Boehringer Ingelheim International GmbH$1M
  • Alnylam Pharmaceuticals Inc.$980K
  • plus $7.4M from 30 others
$141,276in research payments, 2019–2025

Across 18 payments — averaging $7848.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Nielsen Biosciences, Inc.$80K
  • Pfizer$36K
  • Eli Lilly$23K
  • F. Hoffmann-la Roche AG$2K

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$31,831,104 in reported general payments places this provider in the 95th percentile of 6,006 emergency medicine providers in California.

See all emergency medicine providers in California

Medicare billing

Part B allowed, 2024
$3,604
Medicare patients
20
Services billed
32

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other emergency medicine in Chula Vista

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →